Pro Share Advisors LLC Day One Biopharmaceuticals, Inc. Transaction History
Pro Share Advisors LLC
- $36.5 Billion
- Q2 2024
A detailed history of Pro Share Advisors LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,787 shares of DAWN stock, worth $194,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,787
Previous 17,379
20.67%
Holding current value
$194,396
Previous $287,000
34.15%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DAWN
# of Institutions
165Shares Held
71.7MCall Options Held
163KPut Options Held
183K-
Ra Capital Management, L.P. Boston, MA7.87MShares$111 Million1.63% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$90.7 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$65.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$63.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.78MShares$53.3 Million0.02% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.04B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...